Lisanti Capital Growth LLC Lowers Stock Position in Exact Sciences Co. (NASDAQ:EXAS)

Lisanti Capital Growth LLC reduced its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 71.8% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,720 shares of the medical research company’s stock after selling 52,810 shares […]

Related Keywords

United States ,Sarah Condella ,Piper Sandler ,Brian Baranick ,Sanfordc Bernstein ,Sciences Stock Performance ,Vanguard Group Inc ,Goldman Sachs Group ,Insider Activity At Exact Sciences ,News Ratings For Exact Sciences Daily ,Sciences Profile ,Securities Exchange Commission ,Marshall Wace ,Nasdaq ,Norges Bank ,Quarter For Exact Sciences ,Artisan Partners Limited Partnership ,Lisanti Capital Growth ,Sciences Co ,Sciences Corporation ,Exact Sciences ,Free Report ,Capital Growth ,Partners Limited Partnership ,World Investors ,Vanguard Group ,Recurrence Score Test ,Score Test ,Oncoextra Test ,Visit Holdingschannel ,Exact Sciences Daily ,Nasdaq Exas ,Texas ,Medical ,30063p10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,